Jakobsen, Gunnhild
Sjue, Karin
Paulsen, Ørnulf
Kaasa, Stein
Hjermstad, Marianne Jensen
Klepstad, Pål
Funding for this research was provided by:
The Liaison Committee for education, research and innovation in Central Norway (46083200)
Cancer Foundation, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway (15/9116-115/NISLIN)
NTNU Norwegian University of Science and Technology
Article History
Received: 10 June 2022
Accepted: 9 December 2022
First Online: 19 December 2022
Declarations
:
: The authors declare no competing interests.
: This trial is conducted in accordance with ethical principles that have their origin in the Declaration of Helsinki and are consistent with ICH/Good Clinical Practice and applicable regulatory requirements. The Regional Committee for Medical and Health Research Ethics, Section C, South East Norway, approved the final version of the protocol (Sleep RCT_270215) prior to the start of the trial (approval number 2016/353).
: Informed consent was obtained from all individual participants included in the study.